Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:977-979
Published online before print January 22, 2009, doi: 10.1161/STROKEAHA.108.525105
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/977    most recent
STROKEAHA.108.525105v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shantikumar, S.
Right arrow Articles by Carter, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shantikumar, S.
Right arrow Articles by Carter, A. M.
Related Collections
Right arrow Acute Cerebral Infarction

(Stroke. 2009;40:977.)
© 2009 American Heart Association, Inc.


Research Letters

Elevated C-Reactive Protein and Long-Term Mortality After Ischaemic Stroke

Relationship With Markers of Endothelial Cell and Platelet Activation

Saran Shantikumar, MBChB; Peter J. Grant, MD; Andrew J. Catto, PhD; John M. Bamford, MD Angela M. Carter, PhD

From the Division of Cardiovascular and Diabetes Research (S.S., P.J.G., A.J.C., A.M.C.), The LIGHT Institute, University of Leeds, Leeds, UK; Department of Neurology (J.M.B.), Leeds General Infirmary, Leeds, UK.

Correspondence to Dr Angela M. Carter, Division of Cardiovascular and Diabetes Research, The LIGHT Laboratories, Clarendon Way, University of Leeds, LS2 9JT, UK. E-mail a.carter{at}leeds.ac.uk

Background and Purpose— Inflammatory biomarkers predict development of atherothrombotic events. In the present study we examined the relationships between C-reactive protein (CRP), complement C3, and long-term mortality after acute ischemic stroke.

Methods— CRP and C3 were analyzed by in-house enzyme-linked immunosorbent assay in 394 subjects with acute ischemic stroke who survived for >30 days, followed-up for a median of 7.4 years.

Results— CRP was higher in subjects who died (10.8 mg/L; 95% CI, 9.1–12.8) compared with survivors (3.8 mg/L; 95% CI, 3.1–4.7), whereas C3 was similar in both groups (P=0.26). CRP remained predictive for mortality after adjusting for conventional clinical and demographic risk factors (the adjusted hazard ratio for those with CRP in the highest compared with the lowest quartile was 2.0; 95% CI, 1.3–3.1). However, CRP was no longer independently predictive of mortality after additionally adjusting for β-thromboglobulin or von Willebrand factor.

Conclusions— Our data suggest that the relationship between CRP and poststroke mortality may in part reflect inflammation-induced endothelial cell dysfunction and platelet activation.


Key Words: C-reactive protein • cerebral infarction • endothelial cell dysfunction • mortality • platelet activation




This article has been cited by other articles:


Home page
StrokeHome page
K. Tsuda
C-Reactive Protein and Nitric Oxide Production in Ischemic Stroke
Stroke, June 1, 2009; 40(6): e471 - e471.
[Full Text] [PDF]


Home page
StrokeHome page
A. M. Carter
Response to Letter by Tsuda
Stroke, June 1, 2009; 40(6): e472 - e472.
[Full Text] [PDF]